Evaluating The Role Of Corticosteroids In Post-Ureteroscopy Recovery For Urinary Calculi
Status: Recruiting
Location: See location...
Intervention Type: Drug, Other
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
The purpose of this research is to evaluate if corticosteroid (prednisone) after ureteroscopy and placement of the stent will help alleviate postoperative pain control in addition to other normal postoperative pain medications
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patients who are diagnosed with kidney or ureteral stones confirmed on imaging (CT of the abdomen or pelvis) and who elect for definitive treatment via ureteroscopy with placement of ureteral stent.
• Age 18 years or older
• Patients of either gender
• Patients of all ethnic backgrounds
• Cable of giving informed consent
• Capable and willing to fulfill the requirements of the study.
Locations
United States
Arizona
Mayo Clinic in Arizona
RECRUITING
Scottsdale
Contact Information
Primary
Rev V. Vilasan Shylaja
480-574-1466
Time Frame
Start Date: 2026-01-23
Estimated Completion Date: 2027-12-01
Participants
Target number of participants: 90
Treatments
Experimental: Standard of care plus Corticosteroid
Participants will receive standard of care postoperative ureteroscopy medication, with the addition of prednisone 25 mg.
Placebo_comparator: Standard of Care
Participants will receive standard of care postoperative ureteroscopy medication, with the addition of a placebo pill.
Related Therapeutic Areas
Sponsors
Leads: Mayo Clinic